Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences 11/13/2023 Earnings Report

Emmaus Life Sciences logo
$0.01 0.00 (-9.17%)
As of 08/29/2025 02:25 PM Eastern

Emmaus Life Sciences EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Emmaus Life Sciences Revenue Results

Actual Revenue
$5.02 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Emmaus Life Sciences Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Emmaus Life Sciences Earnings Headlines

Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
See More Emmaus Life Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Emmaus Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Emmaus Life Sciences and other key companies, straight to your email.

About Emmaus Life Sciences

Emmaus Life Sciences (OTCMKTS:EMMA), a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

View Emmaus Life Sciences Profile

More Earnings Resources from MarketBeat